About
0.31USD-0.01 -4.08%
Closed • Updated at 21:50 GMT+00:00Market Cap$6.10M
Volume11.14M
Beta2.86
RSI74.54
Gross Margin-14976.66%
Virax Biolabs Group Limited — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 31 2026
Virax Biolabs Achieves ISO Certifications, Laying Foundation for Regulated IVD Development and U.S. Clinical Validation
Dec 4 2025
Virax Biolabs Group Limited Announces Closing of $5 Million Private Placement
Dec 3 2025
Virax Biolabs Group Limited Announces $5 Million Private Placement
Dec 3 2025
Virax Biolabs' CEO James Foster Outlines Clinical Progress and 2026 Priorities in Latest Annual Letter to Shareholders
Nov 3 2025
Virax Biolabs Completes UK Clinical Recruitment and Reports Constructive FDA Feedback for ViraxImmune™ Study Evaluating T Cell Dysfunction in Post-Acute Infection Syndromes
Google Übersetzer